OVERVIEW
Join us on Wednesday, April 23rd 2025 as we come together to shed light on Metabolic Health and Mental Illness. This is an evolving research area that brings together researchers, clinicians, patients, foundations, families, and community members all with a common goal of understanding and treating mental illness through novel approaches. Hear from the Founder of the field of Mitochondrial Medicine, Basic and Translational Scientists, Clinicians, and those with Lived Experience to learn about Mitochondria, Metabolic, and Brain Health. The day will encompass keynote speakers, expert panel sessions, trainee poster sessions & awards, and a networking social.
***Abstract Submissions for Poster Sessions
All trainees are welcome to submit an abstract for the trainee poster session taking place at the meeting.
Poster Themes in the areas of mitochondria metabolism and mental health can include any of the following fields:
Molecular Science
Clinical Science
Translational Science
Submission Instructions:
In a Word Document, format your structured abstract in 150-300 words and use the headings below:
Abstract(s): 150-300 words
1. First and Last Name, including degrees
2. Email Address
3. Supervisor and Institution
4. Theme (Molecular Science, Clinical Science, Translational Science)
5. Title
6. Keywords
7. Background or Introduction
8. Objectives
9. Methods
10. Results
11. Conclusion
More details on submission instructions will be announced soon!
Email mito2i@utoronto.ca for any questions!
Registration and Cost
| Ticket Type | Cost |
| Faculty, Clinicians, Research | $65.00 |
| Student/Fellow | $25.00 |
| Lived Experience/ Patient | Free |
Preliminary Agenda
| 8:30 AM – 8:55 AM | Registration + Coffee |
| 8:55 AM- 9:00 AM |
Welcome Remarks Chair/Co-chair Ana Andreazza, Professor of Pharmacology and Toxicology & Psychiatry, UofT Rob Mccullumsmith, Professor, Chair, Research Director, Neurosciences Institute in the College of Medicine and Life Sciences, UToledo
|
| 9:00 AM – 9:45 AM |
Keynote Speaker Douglas Wallace, Director, of the Centre for Mitochondrial and Epigenomi Medicine, Children’s Hospital of Philadephia |
| 9:45 AM – 10:00 AM | Discussion |
| Panel Section 1: Molecular + Translational | |
| 10:00 AM – 10:20 AM |
Panelist 1 Zoltan Sarnyai, Professor and Head, Laboratory of Psychiatric Neuroscience, James Cook University |
| 10:20 AM – 10:40 AM |
Panelist 2 Denise Potter, RDN, CDCES, Advanced Ketogenic Therapies |
| 10:40 AM – 11:00 AM | Trainee Presentation |
| 11:00 AM – 11:30 AM | Panel Discussion |
| 11:30 AM – 1:30 PM | Poster Session + Lunch |
| 1:30 PM – 2:15 PM |
Keynote Speaker: Rachel Upthegrove, Professor of Psychiatry and Youth Mental Health, University of Birmingham and Consultant Psychiatrist in Birmingham Early Intervention in Psychosis |
| 2:15 PM – 2:30 PM | Discussion |
| Panel 2: Clinical + Translational | |
| 2:30 PM – 2:50 PM |
Panelist 1 Mary L Phillips, Professor of Psychiatry, Clinical and Translational Science, and Bioengineering, and Pittsburgh Foundation-Emmerling Endowed Chair in Psychotic Disorders |
| 2:50 PM – 3:10 PM |
Panelist 2 Sanjeev Sockalingham, Vice Chair and Professor of Psychiatry at the University of Toronto and Vice President, Education at the Centre for Addiction and Mental Health |
| 3:10 PM – 3:30 PM | Trainee Presentation |
| 3:30 PM – 4:00 PM | Panel Discussion |
| 4:00 PM – 4:15 PM | Coffee Break |
| Lived Experience Panel + Discussion | |
| 4:15 PM – 5:00 PM |
Panelists: Moderators: Margaret Hahn, Professor of Psychiatry, University of Toronto, Clinician-Scientist in the Schizophrenia Division, Centre for Addiction and Mental Health Mahavir Agarwal, Assistant Professor in Department of Psychiatry, UofT, Scientis in the Schizophrenia Division, Centre for Addiction and Mental Health |
| 5:00 PM – 5:15 PM |
Poster Award and Closing Statements |
| 5:30 PM – 6:00 PM |
Networking with light refreshments |
ORGANIZING COMMITTEE
Ana Andreazza
Professor, Department of Pharmacology and Toxicology & Psychiatry, Scientific Director, Mitochondrial Innovation Initiative, University of Toronto
Robert McCullum Smith
Professor, Chair, Research Director, Neurosciences Institute in the College of Medicine and Life Sciences, University of Toledo
Margaret Hahn
Professor, Department of Psychiatry, University of Toronto, Senior Scientist, Campbell Family Mental Health Research Institute Centre of Addiction and Mental Health
Dost Ongur
Professor of Psychiatry, Harvard Medical School, Chief of the Division of Psychiatric Disorders, Director, Schizophrenia and Bipolar Disorder Research Program
Julie Milder
Director of Neuroscience, Baszucki Group
Kirk Nylen
Managing Director, Neuroscience, Baszucki Group
SUPPORTING COMMITTEE
Sonya Brijbassi
Associate Director, MITO2i
Erika Leigh Beroncal
Project Manager, MITO2i
Druphadi Sen
Research Communications Assistant, MITO2i
